Avian, the brokerage firm, has recently decreased the rating on Brightpoint (CELL). They lowered the rating from Positive to Neutral. The brokerage firm believes the company is on the downswing and there could be potential savings or capital preservation in selling the stock now. Shares of CELL traded higher by 5.48% or $0.601/share to $11.57. In the past year, the shares have traded as low as $7.37 and as high as $13.22. On average, 575398 shares of CELL exchange hands on a given day and today's volume is recorded at 871209.
Acorda Therapeutics (ACOR) recently had their rating changed from Neutral to Buy. MKM Partners is the brokerage firm which is currently analyzing this company and found it necessary to change their rating. This is usually a bullish sign for the company's share price, as these brokerages begin to tell their clients to start buying the upgraded stock. The shares may see a continued uptrend because of this. Analysts believe that the company's share price may begin to improve. The target price is currently set at $32 per share by the brokerage firm. Shares of ACOR traded higher by 1.83% or $0.47/share to $26.15. In the past year, the shares have traded as low as $18.36 and as high as $33.48. On average, 447311 shares of ACOR exchange hands on a given day and today's volume is recorded at 1015632.
Fossil (FOSL) recently had their rating changed from Hold to Buy. Brean Murray is the brokerage firm which is currently analyzing this company and found it necessary to change their rating. This is usually a bullish sign for the company's share price, as these brokerages begin to tell their clients to start buying the upgraded stock. The shares may see a continued uptrend because of this. Analysts believe that the company's share price may begin to improve. The target price is currently set at $100 per share by the brokerage firm. Shares of FOSL traded higher by 0.73% or $0.57/share to $79.03. In the past year, the shares have traded as low as $66.05 and as high as $134.98. On average, 1234040 shares of FOSL exchange hands on a given day and today's volume is recorded at 965742.
IPC The Hospitalist (IPCM) recently had their rating decreased from Buy to Neutral. Dougherty & Company is the brokerage firm which is currently analyzing this company and found it necessary to change their rating. This is usually a bearish sign for the stock, and this brokerage house may tell its clients to sell the stock. The share prices may fall because of this action. Analysts believe that the company's share price may begin to fall. The target price is currently set at $41 per share by the brokerage firm. Shares of IPCM fell by 31.37% or $-14.32/share to $31.33. In the past year, the shares have traded as low as $35.08 and as high as $52.25. On average, 139132 shares of IPCM exchange hands on a given day and today's volume is recorded at 2793948.
Choice Hotels (CHH) recently had their rating decreased from Neutral to Sell. MKM Partners is the brokerage firm which is currently analyzing this company and found it necessary to change their rating. This is usually a bearish sign for the stock, and this brokerage house may tell its clients to sell the stock. The share prices may fall because of this action. Analysts believe that the company's share price may begin to fall. The target price is currently set at $32 per share by the brokerage firm. Shares of CHH traded higher by 0.22% or $0.08/share to $37.12. In the past year, the shares have traded as low as $26.31 and as high as $41.42. On average, 170832 shares of CHH exchange hands on a given day and today's volume is recorded at 169868.